Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Special Issue on Artificial Organs and Regenerative Medicine dedicated to the late Prof. Yukihiko Nosé
Article type: Research Article
Authors: Hanazaki, Kazuhiro; | Yatabe, Tomoaki | Kobayashi, Masaki | Tsukamoto, Yuuki | Kinoshita, Yoshihiko | Munekage, Masaya | Kitagawa, Hiroyuki
Affiliations: Department of Surgery, Kochi Medical School, Kochi University, Kochi, Japan | Department of Anesthesiology and Critical Care Medicine, Kochi Medical School, Kochi University, Kochi, Japan | Nikkiso Co., Ltd., Tokyo, Japan
Note: [] Address for correspondence: Kazuhiro Hanazaki, MD, PhD, Chairman and Professor, Department of Surgery, Kochi Medical School, Kochi University, Kohasu, Okocho, Nankoku-City, Kochi 783-8505, Japan. Tel.: +81 88 880 2370; Fax: +81 88 880 2371; E-mail: hanazaki@kochi-u.ac.jp
Abstract: I dedicate this paper to the late Prof. Yukihiko Nosé with all my heart. In 2001, under the direction of Prof. Nosé and Prof. Brunicardi at Baylor College of Medicine, we published a review article entitled “Artificial endocrine pancreas” in JACS. Subsequently, we reported that perioperative tight glycemic control (TGC) using an artificial pancreas (AP) with a closed-loop system could stably maintain near-normoglycemia in total-pancreatectomized dogs. Based on this experimental study in Houston, since 2006, we have introduced perioperative TGC using an AP into clinical use in Kochi. As of 2011, this novel TGC method has provided safe and stable blood glucose levels in more than 400 surgical patients. In this paper, we report new clinical findings regarding perioperative TGC using an AP in total-pancreatectomized patients. TGC using an AP enables us to achieve stable glycemic control not only without hypoglycemia and hyperglycemia but also with less variation in blood glucose concentration from the target blood glucose range, even in patients with the most serious form of diabetes, so-called “brittle diabetes”, undergoing total pancreatectomy. To the best of our knowledge, this is the first clinical report of TGC using an AP in patients undergoing total pancreatic resection.
Keywords: Total pancreatectomy, artificial endocrine pancreas, intensive insulin therapy, tight glycemic control, pancreatogenic diabetes
DOI: 10.3233/BME-120736
Journal: Bio-Medical Materials and Engineering, vol. 23, no. 1-2, pp. 109-116, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl